Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.
about
Estrogen receptor alpha gene amplification in breast cancer: 25 years of debateEndocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsPrognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG)Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance.ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study.Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer.Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.Absence of estrogen receptor alpha (ESR1) gene amplification in a series of breast cancers in Taiwan.A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification.
P2860
Q24273274-2A0DF751-BFD2-4B42-9CA9-9C8D0BE6502AQ24621116-F042C003-4269-4BAF-BCF4-6A3B7E2BB82BQ34907190-C473F398-3D88-4BC9-A09B-E4DB86F0652BQ34951367-6CD25415-BA2C-4C3C-9AF1-16AEDA7D6F67Q35038441-8BD06160-4DAB-462F-A5A3-995A52B085CFQ35909220-25F48516-9262-43E5-B07C-419FBBFB2E63Q37962586-30CB3FA4-E641-489D-AEA5-07B95EC47653Q38403294-76772BD4-DF90-4043-A63A-B28F1287051EQ39428484-961CAC5D-48A2-4ACB-9997-29D883D18625Q41733530-6DFC814C-B299-4292-BE85-478AC639AAB9Q42535435-6C9E9E44-2E01-4568-8EEC-591C66E5E3C5Q44823361-D7BA5FDE-811F-4DB4-8A22-2CC57D867738Q46799300-CF8D3679-DB79-4466-A6A3-B7E5A6169C8EQ54374707-BB8E9496-A3E0-4937-B9DC-AAF8479A8AD1
P2860
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Amplification of ESR1 may pred ...... ceptor positive breast cancer.
@en
type
label
Amplification of ESR1 may pred ...... ceptor positive breast cancer.
@en
prefLabel
Amplification of ESR1 may pred ...... ceptor positive breast cancer.
@en
P2093
P2860
P1476
Amplification of ESR1 may pred ...... ceptor positive breast cancer.
@en
P2093
Anne-Vibeke Lænkholm
Birgitte B Rasmussen
Eva Balslev
Henning T Mouridsen
Kirsten Vang Nielsen
Peer Christiansen
Susanne Møller
Sven Müller
P2860
P2888
P304
P356
10.1007/S10549-010-0984-Y
P407
P577
2010-06-17T00:00:00Z
P5875
P6179
1048953271